<DOC>
	<DOCNO>NCT00152854</DOCNO>
	<brief_summary>Many patient cancer pain pain fully control opioids ( eg . morphine ) . The addition acetaminophen ( Tylenol ) opioids small study cancer patient demonstrate good pain control without increase side effect . This study determine regular acetaminophen improve pain control add strong opioids patient cancer pain .</brief_summary>
	<brief_title>Acetaminophen Cancer Pain</brief_title>
	<detailed_description>Aim : To assess whether regular oral acetaminophen reduce pain cancer patient already strong opioid regimen . Rationale : It estimate 75 % people advanced cancer suffer significant pain . Many people continue pain despite strong opioids . The rationale behind add additional analgesic different mechanism action attempt improve analgesia without increase side effect . Overview : This double blind , randomise placebo-controlled , crossover trial evaluate whether addition regular acetaminophen reduce pain cancer patient already strong opioid regimen . The study perform ambulatory cancer patient pain believe caused cancer , already stabilise opioid regimen &gt; 60mg/day morphine equivalent . Each patient randomly allocate receive either acetaminophen 1g qid identical appear placebo qid seven-day period , crossed arm seven-day period . Patients complete daily pain diary weekly questionnaire ( Brief Pain Inventory ) comparison make pain score two treatment period . Patient preference two treatment period also evaluate . Research Question : A randomised , double-blind , placebo control crossover trial determine addition regular acetaminophen ( 1g PO qid ) lead improved analgesic control adult cancer patient Princess Margaret Hospital , already strong opioids ( &gt; 60mg morphine equivalents/day ) evaluate daily pain score measure Numerical Rating Scales ( NRS ) Brief Pain Inventory ( BPI ) . Hypothesis : Regular acetaminophen improve pain control cancer patient already strong opioid regimen .</detailed_description>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1 . Patients diagnosed malignancy persistent pain believe investigator due cancer , whose analgesic regimen stabilise &gt; 60mg morphine equivalents/day . 2 . Age &gt; 18 year 3 . Performance status 02 European Cooperative Oncology Group ( ECOG ) Performance Scale 4 . Sufficient English skill able complete daily diary , BPI understand consent form 5 . Signed informed consent 1 . Patient pain ( 0/10 NRS ) . 2 . Patients severe pain exclude , however pain control optimise eligible . 3 . Patient receive radiation therapy six week prior commence study likely require radiotherapy study period . 4 . Patient commence , dose modification , either nonsteroidal antiinflammatory drug ( NSAIDs ) corticosteroid week prior commence study , twoweek study period . 5 . Patient commence chemotherapy hormone therapy 4 week prior study expect commence chemotherapy hormonotherapy study period . Patients stable longterm chemotherapy hormone eligible study . Patients receive high dose steroid antiemetic chemotherapy eligible provide receive steroid study period . 6 . Patient contraindication acetaminophen . 7 . Use acetaminophen 48 hour prior commencement study period . 8 . Abnormal laboratory value : Absolute neutrophil count &lt; 1.5 X 10^9/L white blood cell ( WBC ) count &lt; 3 X 10^9/L Platelet count &lt; 100 X 10^9/L Liver transaminase &gt; 2.5 X upper limit normal Bilirubin &gt; 1.5 X upper limit normal Creatinine &gt; 1.5 X upper limit normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cancer pain</keyword>
	<keyword>acetaminophen</keyword>
	<keyword>opioids</keyword>
</DOC>